share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:拟议出售证券
美股SEC公告 ·  2024/08/03 04:29

Moomoo AI 已提取核心信息

Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,220 shares of common stock on 08/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $47,063, were acquired on 08/01/2024 through a restricted stock vest from the company itself. This transaction follows a previous sale of 1,775 shares by Matsuda in the past three months, which had gross proceeds of $15,988.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,220 shares of common stock on 08/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $47,063, were acquired on 08/01/2024 through a restricted stock vest from the company itself. This transaction follows a previous sale of 1,775 shares by Matsuda in the past three months, which had gross proceeds of $15,988.
根据最新的文件,Arcutis Biotherapeutics, Inc.的官员松田将于2024年08月02日出售5220股普通股。这些股票市场总价值为$47,063,在2024年08月01日通过公司的限制性股票认股之后获得。此次交易跟随了松田在过去三个月内出售的1775股股票,总收入为$15,988。
根据最新的文件,Arcutis Biotherapeutics, Inc.的官员松田将于2024年08月02日出售5220股普通股。这些股票市场总价值为$47,063,在2024年08月01日通过公司的限制性股票认股之后获得。此次交易跟随了松田在过去三个月内出售的1775股股票,总收入为$15,988。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息